If you are a home care provider struggling to coordinate services for patients who have multiple chronic conditions — this project developed an integrated cloud platform that connects patient devices, care teams, and family members into one ecosystem. It was tested with 120 patients across health services in Ireland and Belgium, covering heart failure, diabetes, COPD, and early dementia. The final software release was designed for use beyond the project timeframe.
Home Care Platform That Connects Patients with Multiple Chronic Diseases to Their Care Teams
Imagine someone with diabetes, heart problems, and early memory issues trying to manage all three conditions at home — different doctors, different devices, different apps, none of them talking to each other. ProACT built a single digital platform that pulls all that health data together in one place, so the patient, their family, and their care team can all see what's happening in real time. It was tested with 120 real patients in Ireland and Belgium. Think of it like a shared dashboard for everyone involved in keeping a person healthy at home.
What needed solving
Managing patients with multiple chronic diseases at home is fragmented and expensive — different devices, different apps, different doctors, none connected. Europe spends €700 billion annually on chronic disease management for 50 million multimorbid patients, much of it on avoidable hospital visits that better home monitoring could prevent.
What was built
ProACT delivered a cloud-based integrated care platform with an open API, three progressive software releases (test, trial, and final deployment version), and validated it through proof of concept trials with 120 patients in Ireland and Belgium. The platform covers heart failure, diabetes, COPD, and early dementia detection.
Who needs this
Who can put this to work
If you are a health tech company whose devices or apps work in isolation from other care tools — this project created an open API that lets different technologies plug into a shared care platform. It integrates clinical status information, therapy tools, and activity monitors for conditions like diabetes, heart failure, and COPD. With 14 partners including 2 major ICT companies already involved, the architecture is built for third-party integration.
If you are a health insurer facing rising costs from Europe's 50 million multimorbid patients — this project built cloud-based analytics that measure the relationship between technology use, care network support, and patient outcomes. The platform enables comparison of efficiency and costs across 4 models of care. It was validated with a European feasibility study assessing cultural and political factors for adoption and scalability.
Quick answers
What would it cost to deploy this platform in our organization?
The project data does not include specific licensing fees or deployment costs. The platform was built as an open API ecosystem with cloud-based infrastructure, which typically means subscription-based pricing. Contact the consortium through Trinity College Dublin for commercial terms.
Can this scale beyond a 120-patient trial to thousands of users?
The project included a European feasibility study specifically to assess cultural and political determinants for adoption and scalability. The platform was designed with cloud architecture and an open API, which supports scaling. However, clinical validation at larger scale would likely be needed before full rollout.
Who owns the IP and can we license this technology?
The project was coordinated by Trinity College Dublin with 14 partners across 7 countries. IP is likely shared among consortium members under the Horizon 2020 grant agreement. The consortium included 9 private organizations, suggesting commercial licensing was anticipated. Contact the coordinator for licensing arrangements.
Which chronic conditions does the platform support?
The platform was specifically developed and tested for chronic heart failure, diabetes, and chronic obstructive pulmonary disease (COPD). It also includes tools to support mild cognitive impairment and detect early onset dementia. These cover some of the most expensive chronic conditions in Europe.
How does this integrate with our existing hospital or care IT systems?
ProACT was built around an open API specifically designed to integrate new and existing technologies. The platform aggregates data from various devices and tools into a cloud-based system. Three progressive software releases were produced, with the final version designed for use beyond the project timeframe.
What evidence exists that this actually improves patient outcomes?
Proof of concept trials were conducted with 120 patients in Health Services in Ireland and Belgium, using associated living lab facilities to ensure patient co-design. The cloud analytics were designed to determine correlations between technology use and impact on health and quality of life. Based on available project data, detailed clinical outcome results would need to be requested from the consortium.
Is this compliant with EU health data regulations?
Based on available project data, the project ran clinical trials within official Health Services in Ireland and Belgium, which would require ethics approval and data protection compliance. The project operated under Horizon 2020 rules during 2016-2019. Current GDPR and Medical Device Regulation compliance should be verified with the consortium.
Who built it
The ProACT consortium is notably industry-heavy for a health research project: 6 out of 14 partners are industry players (43%), including what the project describes as 2 of the world's leading ICT companies and the largest home care provider. Three partners are SMEs. With 3 universities and 1 research organization providing the clinical and technical backbone, and 4 other organizations (likely patient groups and service networks), this consortium was clearly built with commercialization in mind. The spread across 7 countries (Austria, Belgium, Spain, Ireland, Italy, Netherlands, UK) gives it a European market perspective, while the proof of concept trials in Irish and Belgian health services provide real-world validation from two different healthcare systems.
- THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLINCoordinator · IE
- TREE TECHNOLOGY SAparticipant · ES
- PHILIPS ELECTRONICS UK LIMITEDparticipant · UK
- ASSOCIAZIONE ITALIANA PER L ASSISTENZA AGLI SPASTICI PROVINCIA DI BOLOGNAparticipant · IT
- TREELOGIC TELEMATICA Y LOGICA RACIONAL PARA LA EMPRESA EUROPEA SLparticipant · ES
- INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUMparticipant · BE
- IBM IRELAND LIMITEDparticipant · IE
- VEREIN ZUR FOERDERUNG ASSISTIERENDER TECHNOLOGIE IN EUROPAparticipant · AT
- PHILIPS ELECTRONICS NEDERLAND BVparticipant · NL
- DUNDALK INSTITUTE OF TECHNOLOGYparticipant · IE
- UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORKparticipant · IE
- EUROPEAN ASSOCIATION OF SERVICE PROVIDERS FOR PERSONS WITH DISABILITIESparticipant · BE
Coordinated by Trinity College Dublin (Ireland). Reach the research team through Trinity's CASALA (Centre for Affective Solutions for Ambient Living Awareness) or the university's technology transfer office.
Talk to the team behind this work.
Want to explore licensing or deploying the ProACT platform in your care organization? SciTransfer can connect you directly with the development team and help structure a pilot agreement.